51
Bradford A Jameson, Anna P Tretiakova, Mark K Haynes: Novel spliced 5-HT1A receptors and methods, kits, and uses relating thereto. Philadelphia Health and Education Corporation, Drinker Biddle & Reath, September 15, 2005: US20050202467-A1

The present invention relates to a novel spliced 5-HT1A receptor and nucleic acids encoding the same and the polypeptides encoded thereby.


52
Darwin J Prockop, Russell G Reiss, John Langell: Stromal cell use. Philadelphia Health and Education Corporation, Morgan Lewis & Bockius, October 21, 2004: US20040208861-A1

The invention relates to the use of marrow stromal cells to enhance hematopoiesis in a mammal.


53

54
Ira B Black, Dale L Woodbury, Darwin J Prockop, Emily Schwarz: Differentiation of bone marrow cells into neuronal cells and uses therefor. Philadelphia Health And Education Corporation, University Of Medicine And Dentistry Of New Jersey, Seed Intellectual Property Law Group Pllc, June 5, 2008: US20080131407-A1

The present invention relates to methods of inducing differentiation of mammalian bone marrow stromal cells into neuronal cells by contacting marrow stromal cells with a neuronal differentiation-inducing compounds. Neuronal differentiation-inducing compounds of the invention include anti-oxidants su ...


55
Peter D Katsikis, Elizabeth S Papazoglou, Margaret A Wheatley, Nadarajan Sundar Babu, Alina Boestcanu: Delivery vehicles, bioactive substances and viral vaccines. Philadelphia Health and Education Corporation, Drinker Biddle & Reath, August 10, 2006: US20060177468-A1

The invention relates to compositions and methods for the safe delivery of a bioactive agent to an animal. Preferably, the bioactive agent is a vaccine, and more preferably, the bioactive agent is a virus.


56
Mark Stearns, Youji Hu, Min Wang: Prostate Cancer-Related Compositions, Methods and Kits Based on DNA Macroarray Proteomics Platforms. Philadelphia Health And Education Corporation, D B A Drexel University College Of Medicine, Drinker Biddle & Reath, September 2, 2010: US20100221753-A1

The invention relates to novel nucleic acids encoding a mammalian PCADM-1 gene, and proteins encoded thereby, whose expression is increased in certain diseases, disorders, or conditions, including, but not limited to, prostate cancer. The invention further relates to methods of detecting and treatin ...


57
Darwin J Prockop, David G Stokes, S Ausim Azizi: Isolated stromal cells for use in the treatment of diseases of the central nervous system. Philadelphia Health And Education Corporation, Seed Intellectual Property Law Group Pllc, August 27, 2009: US20090214492-A1

Methods of treating a human patient having a disease, disorder or condition of the central nervous system are disclosed. The methods include obtaining a bone marrow sample from a human donor, isolating stromal cells from the bone marrow sample, and administering the isolated stromal cells to the cen ...


58
Peter D Katsikis, Alina C Boesteanu, Martin Turner: Role of PI3K p110 delta Signaling in Retroviral Infection and Replication. PHILADELPHIA HEALTH AND EDUCATION CORPORATION d b a Drexel University College of Medicine, The Babraham Institute, June 9, 2011: US20110135655-A1

The invention includes compositions and methods for regulating PI3K p110 delta as an anti-retroviral therapy. The invention includes inhibiting p110 delta, a component of PI3K p110 delta signaling pathway, or any combination thereof in a cell as an anti-retroviral therapeutic approach for treating a ...


59
Mark Stearns, Youji Hu, Min Wang: Prostate Cancer-Related Compositions, Methods and Kits Based on DNA Microarray Proteomics Platforms. Philadelphia Health And Education Corporation d b a Drexel University College of Medicine, May 12, 2011: US20110111979-A1

The invention relates to novel nucleic acids encoding a mammalian PCADM-1 gene, and proteins encoded thereby, whose expression is increased in certain diseases, disorders, or conditions, including, but not limited to, prostate cancer, The invention further relates to methods of detecting and treatin ...


60
Nick LOIZOS, Alessandro FATATIS, Nathan Graeme DOLLOFF: Methods of treating secondary bone tumors with antibodies against pdgfr alpha. Philadelphia Health And Education Corporation D B A Drexel University College, Imclone, February 9, 2012: US20120034244-A1

The invention provides methods of treating bone cancer, particularly metastatic bone cancer, by administering an IGF-IR antagonist and/or a PDGFRα antagonist. The invention also provides antibodies that bind to human PDGFRα and neutralize activation of the receptor. The invention further provides a ...



Click the thumbnails below to visualize the patent trend.